Stock BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases BioNTech SE Xetra

Equities

US09075V1026

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Africa Should Aim for New Vaccines, Therapeutics - Kagame
AQ
BioNTech : INFORMATION INCLUDED AS PART OF THIS FORM 6 K Form 6 K
PU
BioNTech : ASCO 2024
PU
BioNTech : ASCO 2024
PU
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
AQ
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
GL
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP
AQ
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
AQ
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 17 May 2024)
PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 1 June 2022)
PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 22 June 2021)
PU
BioNTech : Publication of the resolutions and system for the remuneration of the members of the management Board (resolution of the AGM on 17 May 2024)
PU
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GL
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
PR
BioNTech : to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas
PU
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
GL
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GL
BioNTech : Corporate Presentation
PU
BioNTech : First Quarter 2024 Financial Report
PU
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. Stock
  5. News BioNTech SE
  6. Press Releases